USPTO serial 98907719
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Bridgewater, NJ, US
Bridgewater, NJ, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter J. Willsey
Peter J. Willsey Kilpatrick Townsend & Stockton LLP701 Pennsylvania Avenue NW, Suite 200Washington, DC 20004United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment of metastasis; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of behcet disease; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; all of the foregoing excluding pharmaceutical preparations for the treatment and prevention of migraines, headaches, and pain | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 3, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 3, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 8, 2026 | NOAC | CORRECTED NOA E-MAILED | — |
| Jan 8, 2026 | NOAC | CORRECTED NOA E-MAILED | — |
| Jan 7, 2026 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jan 5, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 30, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 16, 2025 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 5, 2025 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Sep 9, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 9, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 9, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 9, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 7, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jul 8, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 8, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 6, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 10, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 10, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 10, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 10, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 17, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 17, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 17, 2024 | NWAP | NEW APPLICATION ENTERED | — |